Anna Berkenblit

5.2k citations
36 papers · 3.8k · 5 hit papers · h-index 24

Impact in

Papers in

Anna Berkenblit

36 papers receiving 3.7k citations

Anna Berkenblit's Hit Papers

Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer 2023 · 287 citations
2870+5+11Years since publication100200300400500

Peers

Anna Berkenblit
Comparison fields: 5 of 82
  • Reproductive Medicine 632
  • Pulmonary and Respiratory Medicine 1.2k
  • Pathology and Forensic Medicine 354
  • Oncology 417
  • Cancer Research 201
Replace Ralph Zinner with:
Ralph Zinner United States
Iván Díaz-Padilla Canada
Andréa Varga France
Thibault De La Motte Rouge France
Jesús García-Donás Spain
Wael A. Harb United States
Bo Gao Australia
Gregory R. Friberg United States
Drew Warren Rasco United States
Jakob Dupont United States
Anna Berkenblit relative to Ralph Zinner United States Ralph Zinner's profile →
Citations per field
00.5×2×4×6.5×
Ralph Zinner · 1×
Citations per year

Countries citing papers authored by Anna Berkenblit

Since Specialization
Citations

This map shows the geographic impact of Anna Berkenblit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Berkenblit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Berkenblit more than expected).

Fields of papers citing papers by Anna Berkenblit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Berkenblit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Berkenblit. The network helps show where Anna Berkenblit may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna Berkenblit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Berkenblit Line = papers co-authored together Anna Berkenblit links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Hit paper breakdown →
2009540
2
Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial
Hit paper breakdown →
2013359
3
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
Hit paper breakdown →
2023287
4
Antibody–Drug Conjugates for Cancer Treatment
Hit paper breakdown →
2018274
5 2009264
6 2012243
7
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I
Hit paper breakdown →
2021232
8 2009220
9 2013173
10 2008145
11 2011124
12 2017121
13 200793
14 201192
15 201186
16
Advances in the management of epithelial ovarian cancer.
200582
17 200479
18 200976
19 200564
20 200951

About Anna Berkenblit

Anna Berkenblit is a scholar working on Reproductive Medicine, Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 36 papers that have together received 3.8k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (10 papers), Renal cell carcinoma treatment (10 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Gastric Cancer Management and Outcomes (2 papers) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Reproductive Medicine (632 citations), Pulmonary and Respiratory Medicine (1.2k citations), Pathology and Forensic Medicine (354 citations), Oncology (417 citations) and Cancer Research (201 citations). Anna Berkenblit has collaborated with scholars based in United States, France and Spain. Frequent co-authors include John M. Lambert, Andrew Louis Strahs, Mizue Krygowski, Jay Marshall Feingold, Stephen A. Cannistra, Jill S. Clancy, Gary R. Hudes, Laurence Moore, Janice P. Dutcher and Georg Heß. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, Annals of Oncology, Blood and Seminars in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact